User profiles for "author:Simone Parisi"

SIMONE PARISI

- Verified email at cittadellasalute.to.it - Cited by 2046

Simone Parisi

- Verified email at ualberta.ca - Cited by 574

Serum Jo-1 autoantibody and isolated arthritis in the antisynthetase syndrome: review of the literature and report of the experience of AENEAS collaborative group

L Cavagna, L Nuño, CA Scirè, M Govoni… - Clinical Reviews in …, 2017 - Springer
Anti-Jo-1 is the most frequently detectable antibody in the antisynthetase syndrome (ASSD),
an autoimmune disease characterized by the occurrence of arthritis, myositis, and interstitial …

The unsurprising effectiveness of pre-trained vision models for control

S Parisi, A Rajeswaran… - … on machine learning, 2022 - proceedings.mlr.press
Recent years have seen the emergence of pre-trained representations as a powerful
abstraction for AI applications in computer vision, natural language, and speech. However …

Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study

E Bartoloni, MA Gonzalez-Gay, C Scirè… - Autoimmunity …, 2017 - Elsevier
Objective Arthritis, myositis and interstitial lung disease (ILD) constitute the classic clinical
triad of anti-synthetase syndrome (ASSD). These patients experience other accompanying …

[HTML][HTML] Clinical spectrum time course in anti Jo-1 positive antisynthetase syndrome: results from an international retrospective multicenter study

L Cavagna, L Nuno, CA Scire, M Govoni, FJL Longo… - Medicine, 2015 - journals.lww.com
Anti Jo-1 antibodies are the main markers of the antisynthetase syndrome (ASSD), an
autoimmune disease clinically characterized by the occurrence of arthritis, myositis, and …

[HTML][HTML] Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course

L Cavagna, E Trallero-Araguás, F Meloni… - Journal of clinical …, 2019 - mdpi.com
Antisynthetase syndrome (ASSD) is a rare clinical condition that is characterized by the
occurrence of a classic clinical triad, encompassing myositis, arthritis, and interstitial lung …

Viral arthritis and COVID-19

S Parisi, R Borrelli, S Bianchi, E Fusaro - The Lancet Rheumatology, 2020 - thelancet.com
The current outbreak of COVID19, caused by severe acute respiratory syndrome
coronavirus 2 (SARSCoV2), is characterised by clinical signs and symptoms such as …

[HTML][HTML] Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR …

C Ferri, R De Angelis, D Giuggioli, G Bajocchi… - Autoimmunity …, 2022 - Elsevier
Abstract Introduction Systemic sclerosis (SSc) is characterized by a complex
etiopathogenesis encompassing both host genetic and environmental-infectious/toxic …

Interesting object, curious agent: Learning task-agnostic exploration

S Parisi, V Dean, D Pathak… - Advances in Neural …, 2021 - proceedings.neurips.cc
Common approaches for task-agnostic exploration learn tabula-rasa--the agent assumes
isolated environments and no prior knowledge or experience. However, in the real world …

COVID‐19 vaccination in autoimmune diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies

A Gil‐Vila, N Ravichandran… - Muscle & …, 2022 - Wiley Online Library
Abstract Introduction/Aims In this study we investigated COVID‐19 vaccination–related
adverse events (ADEs) 7 days postvaccination in patients with idiopathic inflammatory …

[HTML][HTML] Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study

I Buondonno, G Rovera, F Sassi, MM Rigoni… - PLoS …, 2017 - journals.plos.org
The aim of this study was to evaluate differences in T helper cell sub-types and osteoclast
(OCs) precursors in peripheral blood between patients affected by early rheumatoid arthritis …